2008 Jan Feb March April May |
May
|
May 3
|
CLARIFICATION: Hydrocortisone tablets
Only generic hydrocortisone tablets 10mg and 20mg are available from Auden
Mckenzie, not Hydrocortone-branded hydrocortisone tablets as stated in
last week’s Journal (p502).
|
April
|
April 26
|
CLARIFICATION: Headache paper
We have received an update on the affiliations of authors of the paper
entitled “Guidelines
for community pharmacists on the management of headache” (PJ,
15 March 2008, p311).
Sally Greensmith was working for Guildford and Waverley
Primary Care Trust when that article
was researched
and written. She then moved to the National Prescribing Centre for two
years until March 2007. The article did not form part of her role with
the NPC. She is now community pharmacy development lead for South East
Coast Strategic Health Authority.
Lisa Jamieson now works in the new Surrey
PCT.
CORRECTION: Alison Moore
The letter by Alison
Moore published last week (p471) was from Mrs A. M.
Moore, of Dumfries, and not Dr A. Moore, of London, as stated. |
April 5
|
Tribute to Arthur Pipe
A transcription error last week led to Arthur Pipe being described as a
superintendent chemist in Cardiff at the end of the 1939–45 war (p381).
In fact, he held this position at the start of the war. |
March
|
March 29
|
AstraZeneca news
Symbicort is one of the four AstraZeneca products involved in the company’s “Making
the most of your medicines” scheme and not Singulair as stated in a news item
last week (p327). The training described is being provided by NPC Plus, not the
National Prescribing Centre itself.
David Kent’s letter
In the letter from David Kent published last week (p334), the percentage mentioned
in the fourth to last paragraph should have been 0.28 per cent and not 0.0028
per cent.
Grainger
The wife of the late Herbert Grainger died not long after their diamond wedding
anniversary, and not their golden wedding anniversary as stated in last week’s
issue (p348). |
March 22
|
Seretide 500
The Scottish Medicines Consortium rejected salmeterol/fluticasone propionate
50/500µg (Seretide 500 Accuhaler) for the
symptomatic treatment of patients with chronic obstructive airways disease
(COPD) with a forced expiratory volume in 1 second (FEV1) 50 to 60 per
cent of predicted normal (pre-bronchodilator) and a history of repeated
exacerbations, who have significant symptoms despite regular bronchodilator
therapy.
It has not been rejected for all COPD patients as suggested
in last week’s News (PJ, 15
March 2008, p299). |
March 8
|
Avatars
The front cover text and the headline of last week’s article
on virtual patients (p249) should have read “Avatars” (not “Atavars”,
as printed).
|
February
|
February 2
|
Clarification: Conal Farry’s letter
The letter from Conal
Farry (PJ, 26 January 2008, p81) was headed “Statutory
Committee”. The Royal Pharmaceutical Society has asked us to point
out that although the case referred to was a Statutory Committee inquiry,
it was heard and the determination given by the Disciplinary Committee
sitting under the Statutory Committee rules, as provided for in Schedule
2 (Part 1) to the Pharmacists and Pharmacy Technicians Order 2007.
|
January
|
January 26
|
Clarification: Interim suspensions
The Royal Pharmaceutical Society wishes to clarify its position on interim
suspensions of unincorporated sole practitioner pharmacists who become
suspended under the Pharmacists and Pharmacy Technicians Order 2007 (PJ,
5/12 January, p5). It wishes to be reassured that such pharmacists can
put in place arrangements that both maintain protection of the public and
allow pharmacy services to continue to be lawfully provided from the premises.
Correction: IPG newsletter
The article titled “MHRA launches a new strategy to curb trade in
counterfeit medicines” in last month’s Industrial Pharmacists
Group newsletter (PJ, 22/29 December 2007 PDF 250K) was written
by John Kerridge, quality leader at Lilly UK, not Mike Murray as published.
Mr Murray wrote
the text in the panel “2-D data matrix coding: a system to combat
ounterfeiting”. |
January 5/12
|
Jean Coote
Information about Jean Coote was incorrect in the 22/29 December 2007 issue
of the Journal (p717).
She
is currently responsible for the management of the pharmacy service at
the Royal Alexandra Hospital, Paisley, and for
pharmaceutical care in NHS Greater Glasgow and Clyde. She was previously
a clinical pharmacy area specialist and teacher practitioner and honorary
lecturer in association with the University of Strathclyde.
The Journal was given incorrect information. |
Acrobat
Reader